We evaluated hepatocyte paraffin 1 (HepPar1) antigen expression, a sensitive marker of small intestinal differentiation, in combination with morphologic features to demonstrate intestinal differentiation in cases equivocal for Barrett esophagus (BE). Clinicopathologic features and HepPar1 expression were recorded for 54 BE cases, 45 consistent with reflux esophagitis (RE) cases, and 65 "suspicious" for BE (SBE) cases. The SBE category included RE cases with 2 or more morphologic changes associated with BE or metaplastic reaction to injury (eg, multilayered epithelium, squamous islands, goblet cell mimickers, pancreatic metaplasia). HepPar1 was expressed in all 54 BE cases, 4 of 45 RE cases, and 24 of 65 SBE cases. In SBE cases, 2 or more morphologic changes were associated with HepPar1 expression in 37% of cases (24/65), 3 or more features in 59% (13/22), and 4 or more features in 100% (4/4) (P ≤ .004). The combination of certain morphologic changes and HepPar1 expression in clinically suspicious distal esophageal biopsy cases without goblet cells supports the presence of evolving intestinal metaplasia.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3806975 | PMC |
| http://dx.doi.org/10.1309/AJCPYOBVGS4CGA8Y | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Unravelling switch/sucrose non-fermentable (SWI-SNF) complex-deficient thoracic tumours: a clinicopathological comparative on undifferentiated tumours and non-small cell lung carcinomas with BRG1 and BRM deficiency.
J Clin Pathol
November 2024
Department of Pathology, All India Institute of Medical Sciences (AIIMS), New Delhi, India
Aims: This study was undertaken to compare and expand the clinicopathological characteristics of SMARCA4-deficient thoracic undifferentiated tumour (SMARCA4-dUT) and switch/sucrose non-fermentable-deficient non-small cell lung carcinomas (SWI/SNF-dNSCLC) and to address cases with intermediate features.
Methods: The pathology department archive was searched for all primary mediastinal, pleural and lung-based malignancies that showed aberrant expression of two SWI/SNF proteins the Brahma (BRM) aka and/or (Brahma-related gene 1 (BRG1) aka . Patient demographics, treatment and clinical outcomes were collected from records and telephonic interviews.
Hepatic adenosquamous carcinoma with sarcomatous transformation: a case report and review of the literature.
Med Mol Morphol
March 2025
Department of Human Pathology, Kanazawa University Graduate School of Medical Sciences, 13-1 Takaramachi, Kanazawa, Ishikawa, 920-8640, Japan.
Article Synopsis
- Adenosquamous carcinoma (ASC) with a sarcomatous element is a rare form of intrahepatic cholangiocarcinoma (iCCA), and this case focuses on a unique occurrence involving rhabdoid transformation.
- A 72-year-old male presented with a large neoplastic lesion in the right hepatic duct, and subsequent surgery revealed a tumor composed of both ASC and a sarcomatoid carcinoma component with distinct immunohistochemical profiles.
- Unfortunately, the patient experienced liver failure and passed away three months post-surgery, highlighting the aggressive nature of this uncommon cancer variant and emphasizing the need for improved diagnostic and treatment strategies.
HEPPAR1 and PIWIL2 as Panel Markers for Hepatocellular Carcinoma.
Asian Pac J Cancer Prev
June 2024
Department of Biochemistry and Molecular Biology, Theodor Bilharz Research Institute, Giza, Egypt.
Objective: The aim of this study was to evaluate the expression profiles of PIWI-like protein- 2 (PIWIL2), and HepPar1 and their immunohistochemical (IHC) characteristics in Hepatocellular Carcinoma (HCC), and determine their correlation with clinicopathological parameters of this type of cancer to determine their diagnostic value in combination.
Methods: Seventy-five patients with HCC were assessed for the expression of PIWIL2 in serum and tissue using real-time polymerase chain reaction (RT-PCR) and IHC was performed for PIWIL2 and HepPar1 was performed on all patients.
Results: A statistically significantly higher level of PIWIL2 was found in HCC compared to controls (p≤0.
Immunophenotypes and Tumor Immune Microenvironment in Hepatocellular Carcinoma With Macrotrabecular Massive and Vessels Encapsulating Tumor Clusters.
In Vivo
March 2024
Department of Pathology, Kurume University School of Medicine, Kurume, Japan.
Article Synopsis
- The study investigates two aggressive types of hepatocellular carcinoma (HCC): macrotrabecular massive (MTM) pattern and vessels encapsulating tumor clusters (VETC) pattern, focusing on their immunophenotypes and tumor immune microenvironment (TIME).
- It analyzes 74 cases of previously diagnosed HCC, revealing that MTM-HCC has distinct characteristics, including higher PD-L1 expression (associated with immune suppression) compared to VETC-HCC and conventional HCC.
- Findings suggest that although both patterns exhibit an immunosuppressive TIME, they consist of different elements, and transitioning TIME from suppressive to active could improve the efficacy of immune checkpoint inhibitors in treatment.
Enteroblastic cholangiocarcinoma: An uncommon, underrecognized subtype of bile duct cancer.
Hum Pathol
February 2024
Institute of Liver Studies, King's College Hospital, London, SE5 9RS, UK. Electronic address:
Article Synopsis
- - Enteroblastic carcinoma is linked to high alpha-fetoprotein (AFP) levels and is marked by cancer cells with clear cytoplasm and distinct chromatin patterns; it's often related to hepatoid carcinoma.
- - A study examined four rare cases of enteroblastic cholangiocarcinoma, located in the liver and bile duct, with most cases showing similar microscopic features and elevated AFP levels.
- - While enteroblastic cholangiocarcinoma typically appears in the extrahepatic areas, it can also arise in the liver, especially in patients with primary sclerosing cholangitis, and may sometimes be confused with 'clear cell' cholangiocarcinoma.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!